Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax
- PMID: 25891812
- PMCID: PMC4455353
- DOI: 10.1179/2047773215Y.0000000013
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax
Abstract
The eradication of malaria will only be possible if effective, well-tolerated medicines kill hypnozoites in vivax and ovale malaria, and thus prevent relapses in patients. Despite progress in the 8-aminoquinoline series, with tafenoquine in Phase III showing clear benefits over primaquine, the drug discovery challenge to identify hypnozoiticidal or hypnozoite-activating compounds has been hampered by the dearth of biological tools and assays, which in turn has been limited by the immense scientific and logistical challenges associated with accessing relevant human tissue and sporozoites. This review summarises the existing drug discovery series and approaches concerning the goal to block relapse.
Keywords: Drug discovery assays; Hypnozoite,; Plasmodium vivax,; Radical cure,; Strategy,.
Figures
References
-
- Molyneux ME. History of discoveries, malaria. Encycl Malar. 2014:1–10.
-
- Grassi B, Feletti R. Sui parassiti della malaria. Rif Med. 1890;6:62–4.
-
- Thayer W. Lectures on the malarial fevers. New York: Appleton; 1897.
-
- Rodrigues T, Prudêncio M, Moreira R, Mota MM, Lopes F. Targeting the liver stage of malaria parasites: a yet unmet goal. J Med Chem [Internet] 2011;55((3)):995–1012. [cited 2012 Jul 18]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22122518. - PubMed
-
- Douglas NM, Simpson JA, Phyo AP, Siswantoro H, Hasugian AR, Kenangalem E et al. Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax. J Infect Dis [Internet] 2013;208((5)):801–812. [cited 2013 Aug 26]. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 3733516&tool.... - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases